(Q54426186)

29 May 2018

title

Deletions of the transcription factor Ikaros in myeloproliferative neoplasms. (English)

1 reference

29 May 2018

author

Francesco Passamonti

3

1 reference

29 May 2018

Daniela Pietra

7

1 reference

29 May 2018

Ashot Harutyunyan

8

1 reference

29 May 2018

Robert Kralovics

12

1 reference

29 May 2018

author name string

R Jäger

1

1 reference

29 May 2018

H Gisslinger

2

1 reference

29 May 2018

E Rumi

4

1 reference

29 May 2018

T Berg

5

1 reference

29 May 2018

B Gisslinger

6

1 reference

29 May 2018

T Klampfl

9

1 reference

29 May 2018

D Olcaydu

10

1 reference

29 May 2018

M Cazzola

11

1 reference

29 May 2018

publication date

27 May 2010

1 reference

29 May 2018

published in

Leukemia

1 reference

29 May 2018

volume

24

1 reference

29 May 2018

issue

7

1 reference

29 May 2018

page(s)

1290-1298

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1038/leu.2010.99

exact match

0 references

cites work

The myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Genetic complexity of myeloproliferative neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

A gain-of-function mutation of JAK2 in myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Mutation in TET2 in myeloid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Taxing sugar-sweetened beverages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Recurring mutations found by sequencing an acute myeloid leukemia genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

The Ikaros gene is required for the development of all lymphoid lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Ikaros dominant negative isoform (Ik6) induces IL-3-independent survival of murine pro-B lymphocytes by activating JAK-STAT and up-regulating Bcl-xl levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Ikaros is critical for B cell differentiation and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Multiple hematopoietic defects and delayed globin switching in Ikaros null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

JAK mutations in high-risk childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

inferred from DOI database lookup

7 January 2021

based on heuristic

A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

inferred from DOI database lookup

7 January 2021

based on heuristic

Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.99

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2010.99

1 reference

29 May 2018

PubMed ID

20508609

1 reference

29 May 2018